Zostum 1.5gm Injection

Zostum 1.5g combines cefoperazone with sulbactam to combat bacterial infections by inhibiting bacterial growth and resistance. Widely used in inpatient care, Zostum 1.5 gm injection helps clinicians manage complex infections with predictable outcomes when administered as prescribed.

Key Benefits:

• Dual-action formulation enhances antibacterial against resistant strains
• Cefoperazone halts bacterial cell wall synthesis
• Sulbactam prevents enzyme-based resistance
• Supports faster symptom improvement, reducing caregiver monitoring burden
• Trusted hospital-grade antibiotic suitable for protocol-based inpatient treatment

Zostum 1.5g injection contains Cefoperazone 1000 mg, a third-generation cephalosporin antibiotic, and Sulbactam 500 mg, a beta-lactamase inhibitor. This combination improves antibacterial coverage by overcoming resistance mechanisms. Together, they deliver enhanced bactericidal action, making inj Zostum 1.5 gm effective against a wide range of gram-positive and gram-negative pathogens encountered in clinical practice.

• Inj Zostum 1.5 gm must be administered only by a qualified healthcare professional
• Reconstitute the vial as per institutional protocol before administration
• Administer via IV or IM route as prescribed by the physician
• Follow the exact inj Zostum 1.5 dose schedule without skipping doses
• Complete the full treatment course, even if symptoms improve early

• Zostum 1.5 gm injection should be used strictly under medical supervision.
• Inform the physician about any history of allergies, or ongoing medications.
• Seek immediate medical attention if allergic reactions occur.
• Pregnant or breastfeeding women must consult a doctor before use.
• Avoid alcohol during therapy to prevent adverse effects.